Icosavax Closes $51M Series A, Officially Launches
Icosavax, which develops vaccines for unmet medical needs, said Thursday that it has hit the ground running with a $51 million Series A financing round that will be used to ready...To view the full article, register now.
Already a subscriber? Click here to view full article